Back to results
US 12,582,638 B2Granted
Pharmaceutical composition for treating cancer, containing mTOR-signaling inhibitor as active ingredient
AssigneeKorea Advanced Institute of Science and Technology
InventorsSeyun Kim, Boah Lee, Seung Ju Park
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating cancer, containing a mTOR-signaling inhibitor as an active ingredient. The composition of the present invention exhibits the efficacy of inhibiting the growth of cancer cells and killing cancer cells, and thus can be used as an anticancer agent.
Claims9
A method for treating cancer comprising:
- administering a composition comprising an mTOR signaling inhibitor as an active ingredient,
- wherein the mTOR signaling inhibitor is lomitapide, a pharmaceutically acceptable salt thereof, or an optical isomer thereof.
Dependencies are inferred from the claim text.